DISC-0974-102
Phase I/II
OPEN TO ACCRUAL
A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-0974 in Participants with Myelofibrosis or Myelodysplastic Syndrome and Anemia
UCHICAGO-IRB23-1681
Phase I
OPEN TO ACCRUAL
A Phase 1b Trial of Ivosidenib Combined with Ruxolitinib in IDH1-Mutated Advanced-Phase MPNs